Skip to main content
. 2010 Jun 16;92(2):450–457. doi: 10.3945/ajcn.2010.29217

TABLE 4.

Changes in maternal bone mineral status at the hip at 13 and 52 wk postpartum1

Percentage change from 2 wk2
13 wk
52 wk
P3
Calcium group (n = 25) Placebo group (n = 27) Calcium group (n = 39) Placebo group (n = 37) Time Group Overall calcium effect4
Total hip
 BMC −4.0 ± 1.25 −6.2 ± 1.56 −7.0 ± 1.66 −8.3 ± 1.56 ≤0.001 0.005 −10.7 (−18.1, −3.4)
 BA −0.7 ± 1.1 −2.0 ± 1.0 −1.3 ± 1.1 −1.9 ± 1.1 0.08 0.05 −3.8 (−7.6, 0.0)
 BMD −3.3 ± 0.97 −4.2 ± 0.86 −5.8 ± 0.968 −6.4 ± 0.969 ≤0.001 0.01 −6.9 (−12.1, −1.7)
 SA-BMC −3.1 ± 0.97 −3.7 ± 0.86 −5.5 ± 0.968 −6.0 ± 0.869 ≤0.001 0.05 −6.0 (−12.0, 0.0)
Femoral shaft
 BMC −2.6 ± 1.5 −5.6 ± 1.46 −5.2 ± 1.57 −7.0 ± 1.46 ≤0.001 0.003 −9.3 (−15.3, −3.3)
 BA 0.3 ± 1.0 −1.7 ± 1.0 0.0 ± 1.0 −1.0 ± 1.0 0.6 0.3 −1.6 (−4.7, 1.5)
 BMD −2.9 ± 0.87 −3.9 ± 0.86 −5.2 ± 0.868 −6.0 ± 0.869 ≤0.001 0.01 −7.7 (−13.4, −1.9)
 SA-BMC −2.9 ± 0.87 −3.6 ± 0.86 −5.2 ± 0.868 −5.8 ± 0.869 ≤0.001 0.02 −7.3 (−13.3, −1.3)
Trochanter
 BMC −6.1 ± 2.9 −6.9 ± 2.75 −10.4 ± 2.97 −10.3 ± 2.87 ≤0.001 0.02 −15.2 (−27.7, −2.7)
 BA −2.0 ± 2.5 −2.1 ± 2.4 −3.6 ± 2.5 −2.4 ± 2.4 0.2 0.05 −7.7 (−15.6, 0.2)
 BMD −4.1 ± 1.37 −4.8 ± 1.36 −6.8 ± 1.36 −7.9 ± 1.369 ≤0.001 0.02 −7.5 (−13.7, −1.3)
 SA-BMC −4.1 ± 1.47 −4.7 ± 1.37 −6.7 ± 1.46 −7.8 ± 1.369 ≤0.001 0.02 −7.1 (−13.1, −1.1)
Femoral neck
 BMC −5.1 ± 2.05 −6.9 ± 1.97 −8.8 ± 2.06 −8.9 ± 2.06 ≤0.001 0.07 −8.5 (−17.7, 0.7)
 BA −1.0 ± 1.7 −2.6 ± 1.6 −1.1 ± 1.7 −2.8 ± 1.6 0.2 0.6 −2.1 (−9.1, 4.9)
 BMD −4.2 ± 1.17 −4.3 ± 1.16 −7.6 ± 1.169 −6.1 ± 1.16 ≤0.001 0.02 −6.4 (−11.6, −1.2)
 SA-BMC −4.2 ± 1.27 −4.2 ± 1.16 −7.6 ± 1.269 −6.1 ± 1.16 ≤0.001 0.02 −6.0 (−11.4, −0.6)
1

Hip scans were conducted by dual-energy X-ray absorptiometry. BMC, bone mineral content; BA, bone area; BMD, bone mineral density; SA-BMC, size-adjusted BMC derived by including BA and body weight in the hierarchical ANCOVA model. Body weight was not a significant independent variable of bone mineral status at the hip and was removed from the models presented.

2

All values are means ± SEs from hierarchical ANOVA and ANCOVA models with continuous variables in natural logarithms that involve subjects nested by group, time, and time × group interaction terms.

3

P values for each component from the model without the interaction term. The time × group interaction term was not significant at any site in the hip.

4

Overall magnitude of group differences expressed as mean (95% CI) percentage differences obtained from hierarchical models without interaction terms and representing the average calcium effect over all 3 time points.

5–7

Significance of differences from 2 to 13 and 52 wk within each group: 5P ≤ 0.05, 6P ≤ 0.001, 7P ≤ 0.01.

8,9

Significance of differences from 13 to 52 wk within each group: 8P ≤ 0.01, 9P ≤ 0.05.